Search

The long-term health effects of exposure to thorium are of interest because of the possible increased use of thorium as an energy source in reactors using 232Th to produce 233U. Mortality is described in a cohort of 3039 men who were employed between 1940 and 1973 at a company involved in the production of thorium and rare earth chemicals from monazite sand. Based on deaths ascertained by the Social Security Administration and mortality rates for U.S. white males, the standardized mortality ratio (SMR) for all causes was 1.05 with 95% confidence limits (95% CL) of 0.96 and 1.15. Much of the excess mortality was attributable to non-occupational motor vehicle accidents (SMR = 1.64; 95% CL = 1.16 and 2.23), but SMRs were also high for lung cancer (1.44; 95% CL = 0.98 and 2.02), pancreatic cancer (2.01; 95% CL = 0.92 and 3.82), and diseases of the respiratory system (1.31; 95% CL=0.92 and 1.83). In a subgroup of 592 men who worked for at least one year in selected jobs (indicative of highest exposure to thorium and thoron) that was followed up more intensively, the SMR for pancreatic cancer was significantly elevated (i.e. 4.13; 95% confidence limits = 1.34 and 9.63). The SMR for lung cancer was 1.68 (95% CL = 0.81 and 3.09), while that for respiratory diseases was 1.20 (95% CL = 0.52 and 2.37). Information on smoking habits in a sample of survivors suggested that smoking could have explained at least part of the excess mortality from lung and pancreatic cancer and from diseases of the respiratory system. Continued follow-up of the cohort through morbidity and mortality studies is needed to evaluate further the possible long-term effects of exposure to radioactivity and chemicals in the thorium extraction process. [ABSTRACT FROM AUTHOR]

Late biological effects of radium deposited in the human skeleton have manifested themselves unequivocally as osteogenic sarcomas or carcinomas of the mastoid air cells or paranasal sinuses. On the basis of current estimated risk factors, it might be expected that an excess of certain other malignancies could occur in a population of the size of the group exposed to radium (some 3500 cases located, of which more than 2000 have measured 226Ra and 228Ra burdens), compared with the incidence in the population at large. An increased incidence of breast cancer has already been reported in female dial workers and it was related to the initial radium intake. On the other hand, very little information is available on the induction of leukaemia by alpha-radiation in human bone marrow. This paper therefore reports an investigation of the incidence of leukaemia among the radium workers. This covers a very wide range of radium burdens and has been done in the light of reasonable estimates of the mean alpha-particle dose received by the skeletal haemopoietic marrow. The number of leukaemia cases is identified and compared with (a) the expected number in a comparable population of the same size and age distribution and (b) predictions based on the risk factor proposed for protection purposes by the ICRP and on the estimated bone marrow doses. [ABSTRACT FROM AUTHOR]

The incidence of bone sarcomas among 3055 female radium-dial workers who entered the dial industry before 1950 was used to determine dose-response relationships for the induction of bone sarcomas by radium. Two subpopulations were analyzed: all measured cases who survived at least 5 yr after the start of employment and all cases who survived at least 2 yr after first measurement. The first constituted a group based on year of entry; it contained 1468 women who experienced 42 bane sarcomas; the expected number was 0.4. The 'second comprised a group based on first measurement; it contained 1257 women who experienced 13 bone sarcomas; the expected number was 0.2. The dose-response function, I = (C + alpha D + beta D2) e-gamma D, and simplifications of this general form, were fit to each data set. Incidence (I) was in units of bone sarcomas per person-yr; (D) was the quantity (μCi) of radium that entered the blood. Two functions, I = (C + alpha D + beta D2) e -gamma D and I = (C + beta D2) e-gamma D, fit the data for year of entry (p ≥ 0.05); both these functions and 1= (C + alpha D) fit the data for first measurement. The function I = (C + beta D2) e-gamma D was used to predict the number of bone sarcomas in all other pre-1950 radium cases (medical, laboratory and other exposures); fewer were actually observed than the fit of this function to the female dial workers predicted. [ABSTRACT FROM AUTHOR]

Concentrations of 232Th and activity ratios of 228Th to 232Th and 230Th to 232Th were determined in autopsy samples from five former employees of a thorium refinery. The ranges of 232Th activity concentrations(mBq per gram of wet tissue) were 0.17-94 in lungs, 3.9-1210 in pulmonary lymph nodes, 0.14-1.19 in bones, 0.015-0.68 in liver, 0.97-5.8 in spleen, and 0.009-0.068 in kidneys. These concentrations are 10 to1,000 times greater than have been reported for persons not occupationally exposed to thorium. In most of the samples, the ratios of 228Th to 232Th and 230Th to 232Th activity at death of the subject were 0.2-0.4 and 0.1-0.2, respectively. 228Th to 228Ra activity ratios ( standard errors) of 0.86 0.11 in lungs and 1.18 0.13 in lymph nodes of one subject were obtained by calculation from ratios of 228Th to 232Th. [ABSTRACT FROM AUTHOR]